Sort
53,477 grants matching “addiction”
Is mental disorder a preventable cause of age-related disease? The Dunedin Study.
$500,898Terrie Edith Moffitt · Duke University · R01 · FY2010 · AG
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$500,895James L. Sorensen · University Of California, San Francisco · UG1 · FY2017 · DA
MOMS STUDY IMPLEMENTATION (CTN-0080). DSC6. 08/15/2023 - 04/30/2026. N01DA-22-2253. TASK ORDER 75N95023F00006 (TO10).
$500,879Jennifer McCormack · The Emmes Company, Llc · N01 · FY2023 · DA
Gene Regulation in Memory Circuits as a Consequence of Polysubstance Use
$500,864Karla R. Kaun · Brown University · R01 · FY2024 · DA
Novel selective alpha4beta2 nicotinic receptor antagonists for smoking cessation
$500,849Jinhua Wu · Assuage Pharmaceuticals, Inc. · R44 · FY2016 · DA
Molecular Studies of Cocaine Action in Brain
$500,833Eric J Nestler · Icahn School Of Medicine At Mount Sinai · R37 · FY2015 · DA
Neural, endocrine, and behavioral markers of psychosocial stress predicting drug use outcomes in human opioid addiction
$500,825Scott J Moeller · State University New York Stony Brook · R01 · FY2021 · DA
KETAMINE FOR METHAMPHETAMINE USE DISORDER STUDY (CTN-0132). 09/28/2022 - 08/21/2025. DSC6. 75N95022F00004 (TO4).
$500,799Jennifer McCormack · The Emmes Company, Llc · N01 · FY2025 · DA
HUMAN GENETIC VARIATION IN SMOKING AND ADDICTION RISK
$500,793Nancy L Saccone · Washington University · R01 · FY2011 · DA
Assessing the role of corticostriatal circuitry in polysubstance use of fentanyl and methamphetamine using rat self-administration models
$500,762Susan Marie Ferguson · University Of Washington · R01 · FY2024 · DA
Maintaining Nonsmoking
$500,711Sharon M. Hall · University Of California, San Francisco · R01 · FY2011 · DA
Hair Ethyl Glucuronide as a Long Term Alcohol Biomarker
$500,707Charles A Plate · U.S. Drug Testing Laboratories, Inc. · R44 · FY2010 · AA
Substance Use in Reservists: Social and Environmental Influences
$500,704Gregory G. Homish · State University Of New York At Buffalo · R01 · FY2019 · DA
Molecular Studies of Cocaine Action in Brain
$500,634Eric J Nestler · Icahn School Of Medicine At Mount Sinai · R37 · FY2013 · DA
Synthesis and Testing of Targeted Libraries to Identify Small-molecule Agonists a
$500,593James B. Thomas · Research Triangle Institute · R33 · FY2012 · DA
Investigating addictive/compulsive feeding behavior
$500,575Michael J. Krashes · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Selective Monoamine Release as a Treatment for Cocaine Use Disorders
$500,484William Walton Stoops · University Of Kentucky · R01 · FY2014 · DA
Optimizing Pharmacotherapy for Bipolar Alcoholics
$500,478Ihsan M Salloum · University Of Miami School Of Medicine · R01 · FY2008 · AA
HIV Tat & Morphine induce mircroglial migration & activation via release of miR-9 & 138
$500,413Shilpa J Buch · University Of Nebraska Medical Center · R01 · FY2015 · DA
HIV Tat & Morphine induce mircroglial migration & activation via release of miR-9 & 138
$500,413Shilpa J Buch · University Of Nebraska Medical Center · R01 · FY2017 · DA
HIV Tat & Morphine induce mircroglial migration & activation via release of miR-9 & 138
$500,413Shilpa J Buch · University Of Nebraska Medical Center · R01 · FY2019 · DA
Molecular Dissection of Active Zone Functions in Neurotransmitter Release
$500,407Pascal Simon Kaeser · Harvard Medical School · R01 · FY2019 · NS
Molecular Dissection of Active Zone Functions in Neurotransmitter Release
$500,407Pascal Simon Kaeser · Harvard Medical School · R01 · FY2021 · NS
Molecular Dissection of Active Zone Functions in Neurotransmitter Release
$500,407Pascal Simon Kaeser · Harvard Medical School · R01 · FY2022 · NS
Molecular Dissection of Active Zone Functions in Neurotransmitter Release
$500,407Pascal Simon Kaeser · Harvard Medical School · R01 · FY2020 · NS